New product aims to give CROs and sponsors a competitive advantage
goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today the release of Analyze, a reporting tool that provides a real-time view into clinical operations data.
With Analyze, study managers now gain deeper, instant insight into performance across accounts, portfolios, studies, countries, and sites. Users can also customize and share reports, internally and externally to members of partnering organizations. Customers can create new reports based on the standard ones available in Analyze, or build new, ad-hoc reports using an easy to use editing interface.
Analyze interacts seamlessly with goBalto’s flagship product, Activate, where information about sites, documents, submissions, milestones, and the status of activities related to them are tracked and managed. Analyze is also hosted in the cloud, so it can be accessed anytime and anywhere.
Analyze enables support for analytics by allowing you to instantly view status, quantify your team’s performance, and discover meaningful patterns in your clinical study startup data.
Recognizing that good data increasingly translates to a competitive advantage for its customers, goBalto built Analyze with the goals of simplicity, completeness, and flexibility. Customizable reports, drag and drop visualizations, and interactive dashboards allow decision makers to make faster, better decisions that improve performance and directly impact their clinical study startup conduct.
“Our customers were eager for a solution like Analyze,” said Andrea Sim, goBalto VP Product. “They’re already embracing all of the advantages that come with using Activate. Now, we’re providing them with the ability to gain even further insight into their study startup status, cycle times, and bottlenecks. Analyze is where big data meets and exceeds our customer’s needs.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.